Australia markets close in 2 hours 36 minutes

Avalo Therapeutics, Inc. (AVTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
11.73-1.52 (-11.47%)
At close: 04:00PM EDT
12.03 +0.30 (+2.56%)
After hours: 07:19PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,924
1,924
18,051
5,398
6,699
Cost of revenue
1,284
1,284
3,434
1,491
300
Gross profit
640
640
14,617
3,907
6,399
Operating expenses
Research development
13,784
13,784
31,308
59,835
32,193
Selling general and administrative
10,300
10,300
20,711
24,658
19,759
Total operating expenses
24,084
24,084
52,057
86,041
53,693
Operating income or loss
-23,444
-23,444
-37,440
-82,134
-47,294
Interest expense
3,417
3,417
4,170
2,391
-
Total other income/expenses net
-4,669
-4,669
-20
-20
-19,932
Income before tax
-31,530
-31,530
-41,630
-84,545
-67,177
Income tax expense
14
14
28
-196
-2,793
Income from continuing operations
-31,544
-31,544
-41,658
-84,349
-64,384
Net income
-31,544
-31,544
-41,658
-84,376
-63,500
Net income available to common shareholders
-31,544
-31,544
-41,658
-84,376
-57,638
Basic EPS
-480.00
-114.00
-1.06k
-2.39k
-2.48k
Diluted EPS
-480.00
-114.00
-1.06k
-2.39k
-2.48k
Basic average shares
85.69
277.727
39.202
35.298
1,283
Diluted average shares
85.69
277.727
39.202
35.298
1,283